Atom Investors’s PetMed Express PETS Stock Holding History

Atom Investors’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-53,976	Closed	-$744K	–	492
2023 Q2	$744K	Buy	+53,976	New	+$810K	0.28%	75
2021 Q4	–	Sell	-23,281	Closed	-$626K	–	372
2021 Q3	$626K	Buy	23,281 +16,740	+256%	+$482K	0.05%	176
2021 Q2	$208K	Buy	+6,541	New	+$208K	0.03%	218

Other funds holding PETS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $2.35B AUM 214.39% 1-Year Est. Return

Atom Investors's PETS Position: Q3 2023 in Review

Atom Investors sold out of PetMed Express (PETS) in Q3 2023, closing a stake of 53,976 shares — an estimated $744K sold.

Atom Investors first reported a position in PETS in Q2 2021 and held it in 3 quarters. The position peaked at $744K in Q2 2023. 138 funds tracked by Wall St. Rank hold PETS as of Q3 2023.

Atom Investors reported no remaining PetMed Express position as of Q3 2023 after selling out during the quarter.
Atom Investors sold 53,976 PetMed Express shares in Q3 2023, an estimated $744K.
Atom Investors first reported a position in PetMed Express in Q2 2021 and held it in 3 quarters.
Atom Investors's PetMed Express position peaked at $744K in Q2 2023.
138 funds tracked by Wall St. Rank held PetMed Express as of Q3 2023.

Based on Atom Investors's 13F filing for Q3 2023, filed 14 Nov 2023.